The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Role of Striatal Serotonin2A and Serotonin2C Receptor Subtypes in the Control of In Vivo Dopamine Outflow in the Rat Striatum
Abstract
Abstract: This study investigated, using in vivo microdialysis in the striatum of freely moving rats, the role of striatal serotonin 2A (5‐HT 2A) and 5‐HT 2C receptor subtypes in the modulation of dopamine (DA) and 3, 4‐dihydroxyphenylacetic acid (DOPAC) outflow, both in basal conditions and under activation induced by subcutaneous administration of 0.01 mg/kg haloperidol. The different 5‐HT 2 agents used were applied intrastriatally at a 1 μ M concentration through the microdialysis probe. Basal DA efflux was enhanced (27%) by the 5‐HT 2A/2B/2C agonist 1‐(4‐iodo‐2,5‐dimethoxyphenyl)‐2‐aminopropane (DOI) and reduced (‐30%) by the 5‐HT 2B/2C antagonist SB 206553. It was unaffected by infusion of the 5‐HT 2A antagonist SR 46349B. The effect of DOI was abolished by SB 206553 but not modified by SR 46349B. Haloperidol‐stimulated DA efflux (65‐70%) was reduced by both SR 46349B (‐32%) and the 5‐HT 2A/2B/2C antagonist ritanserin (‐30%) but not affected by SB 206553. Conversely, the effect of haloperidol was potentiated (22%) when DOI was coperfused with SB 206553. Also, haloperidol‐stimulated DOPAC outflow (40‐45%) was reduced (‐20%) by SR 46349B and potentiated (25%) by the combination of SB 206553 with DOI. These results indicate that striatal 5‐HT 2A receptors, probably through activation of DA synthesis, positively modulate DA outflow only under activated conditions. In contrast, striatal 5‐HT 2C receptors exert a facilitatory control on basal DA efflux, which appears to be both tonic and phasic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors
Smith, R. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00110-5 · Cited by 147
Research works printed but not linked: 47
- 10.1016/0028-3908(95)00138-7 · DOI · Paper page
- 10.1016/S0165-6147(00)88991-9 · DOI · Paper page
- 10.1016/0014-2999(91)90658-D · DOI · Paper page
- Benloucif S., 1993, Serotonin‐facilitated dopamine release in vivo: pharmacological characterization., J. Pharmacol. Exp. Ther., 265, 373
- Boess F.G., 1998, The 5‐hydroxytryptamine6 receptor‐selective radioligand [3H]Ro 63‐0563 labels 5‐hydroxytryptamine receptor binding sites in rat and porcine striatum., Mol. Pharmacol., 54, 373, 10.1124/mol.54.3.577 · DOI
- 10.1016/0028-3908(94)00145-I · DOI
- 10.1046/j.1471-4159.1996.66010210.x · DOI
- 10.1046/j.1471-4159.1997.68010195.x · DOI
- 10.1016/0920-9964(91)90030-U · DOI · Paper page
- 10.1016/S0306-4522(98)00655-1 · DOI · Paper page
- Dray A., 1981, Serotonin in the basal ganglia: functions and interactions with other neuronal pathways., J. Physiol. (Paris), 77, 393
- 10.1016/0006-8993(76)90005-6 · DOI · Paper page
- 10.1016/S0306-4522(96)00480-0 · DOI · Paper page
- 10.1016/0014-2999(94)90669-6 · DOI
- Hoyer D., 1994, International Union of Pharmacology classification of receptors for 5‐hydroxytryptamine (serotonin)., Pharmacol. Rev., 46, 157
- 10.1016/0014-2999(93)90859-G · DOI
- 10.1111/j.1471-4159.1992.tb10975.x · DOI
- 10.1016/0006-8993(95)00865-N · DOI
- 10.1111/j.2042-7158.1980.tb12889.x · doi:10.1111/j.2042-7158.1980.tb12889.x
- 10.1176/ajp.153.4.466 · DOI · Paper page
- 10.1111/j.1476-5381.1996.tb15208.x · DOI · Paper page
- 10.1159/000138761 · doi:10.1159/000138761
- Lejeune F., 1997, Serotonin (5‐HT)2C receptors inhibit the activity of mesocortical and mesolimbic dopaminergic pathways: a combined dialysis and electrophysiological analysis., Soc. Neurosci. Abstr., 23, 975
- Leysen J.E., 1985, Receptor‐binding properties in vitro and in vivo of ritanserin, a very potent and long acting serotonin S2 antagonist., Mol. Pharmacol., 27, 600
- Lucas G., 1997, 8‐OH‐DPAT, a 5‐HT1A agonist and ritanserin, a 5‐HT2A/C antagonist, reverse haloperidol‐induced catalepsy in rats independently of striatal dopamine release., Psychopharmacology (Berl.), 131, 57, 10.1007/s002130050265 · DOI
- Martin‐Ruíz R., 1997, Activation of dopamine D2 receptors in the dorsal raphe nucleus increases firing rate and 5‐HT release in the rat brain., Soc. Neurosci. Abstr., 23, 2328
- Meltzer H.Y., 1991, Effects of antipsychotic drugs on serotonin receptors., Pharmacol. Rev., 43, 587
- 10.1016/S0014-2999(98)00321-5 · DOI
- 10.1016/0306-4522(90)90330-7 · DOI · Paper page
- 10.1016/S0028-3908(98)00078-1 · DOI · Paper page
- Monsma F.J., 1993, Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs., Mol. Pharmacol., 43, 320
- PaxinosG.&WatsonC.(1986)The Rat Brain in Stereotaxic Coordinates 2nd edit. Academic Press Orlando.
- 10.1016/0006-8993(85)90857-1 · DOI · Paper page
- 10.1016/0169-328X(94)90223-2 · DOI · Paper page
- Rinaldi‐Carmona M., 1992, Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5‐hydroxytryptamine2 receptor antagonist., J. Pharmacol. Exp. Ther., 262, 759
- 10.1016/0014-2999(92)90819-P · DOI · Paper page
- 10.1046/j.1471-4159.1994.62041382.x · DOI
- 10.1016/0006-8993(93)91535-Z · DOI · Paper page
- 10.1016/0306-4522(84)90082-4 · DOI
- Spampinato U., 1998, Opposite role of central 5‐HT2A and 5‐HT2C receptor subtypes in the control of haloperidol‐induced release of dopamine in the rat striatum., Soc. Neurosci. Abstr., 24, 108
- 10.1037/0033-2909.112.2.330 · doi:10.1037/0033-2909.112.2.330 · Paper page
- Westphal R.S., 1995, Increased basal phosphorylation of the constitutively active serotonin2C receptor accompanies agonist‐mediated desensitization., Mol. Pharmacol., 48, 200
- 10.1002/cne.903510304 · DOI · Paper page
- Wurtman R.J., 1998, DOI, a 5‐HT2 receptor agonist, increases both DA and 5‐HT release in rat striatum., Soc. Neurosci. Abstr., 24, 1370
- Yamamoto B.K., 1995, Modulation of methylenedioxymethamphetamine‐induced striatal dopamine release by the interaction between serotonin and γ‐aminobutyric acid in the substantia nigra., J. Pharmacol. Exp. Ther., 273, 1063
- 10.1016/0014-2999(86)90002-6 · DOI
- 10.1016/0014-2999(88)90110-0 · DOI · Paper page
Cited by
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Alex, K. D., & Pehek, E. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.004 · Cited by 658
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Huot, P., Johnston, T. H., Koprich, J. B., Fox, S. H., & Brotchie, J. M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005678 · Cited by 324
The serotonergic system in Parkinson's disease
Huot, P., Fox, S. H., & Brotchie, J. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.004 · Cited by 195
Barr, A. M., Lehmann-Masten, V., Paulus, M., Gainetdinov, R. R., Caron, M. G., & Geyer, M. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300343 · Cited by 103
Metadata
- Authors
- Lucas, G., & Spampinato, U.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2000-02
- Volume
- 74
- Issue
- 2
- Pages
- 693-701
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2165194242
- Cited by
- 170
- References
- 1
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of Striatal Serotonin2A and Serotonin2C Receptor Subtypes in the Control of In Vivo Dopamine Outflow in the Rat Striatum. https://app.cochat.ai/papers/10.1046/j.1471-4159.2000.740693.x
- The paper
- Lucas, G., & Spampinato, U. (2000). Role of Striatal Serotonin2A and Serotonin2C Receptor Subtypes in the Control of In Vivo Dopamine Outflow in the Rat Striatum. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.2000.740693.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.